Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
BGC Partners (BGCP) Announces Spin-Off of Newmark (NMRK)
-
BGC Partners Announces Spin-Off of Newmark
-
Amarin (AMRN) Mineral Oil Concerns Not an Oil Spill - Cantor Fitzgerald
-
Albireo Reports Third Quarter 2018 Financial Results
-
EMX Derivatives Exchange Expands Management Team; Former BitMEX Head of Support to open Hong Kong Office
-
PTC Therapeutics (PTCT) PT Lowered to $61 at Cantor Fitzgerald
-
Cantor Fitzgerald Downgrades Pacific Biosciences of California (PACB) to Neutral
-
Denison Reports Results from Q3 2018
-
Colony Credit Real Estate Announces Appointment of New Chief Financial Officer and Chief Accounting Officer
-
Matlin & Partners Acquisition Corporation and U.S. Well Services, LLC Complete Business Combination
-
AcelRx Pharma (ACRX) Prices 12.698M Share Common Offering at $3.15/Sh
-
BioDelivery Sciences International (BDSI) PT Raised to $5 at Cantor Fitzgerald
-
AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Omeros (OMER) Prices $210 Million Offering of Convertible Senior Notes Due 2023
-
AcelRx Pharma (ACRX) Announces Proposed Common Offering
-
Omeros Announces Pricing of $210 Million Offering of Convertible Senior Notes Due 2023
-
AcelRx Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Sarepta Therapeutics (SRPT) Prices 3.187M Share Common Offering at $131/Sh
-
Sarepta Therapeutics Announces Pricing of $500,000,000 Public Offering of Common Stock
-
Omeros (OMER) Proposed $210 Million Offering of Convertible Senior Notes Due 2023
-
Omeros Announces Proposed $210 Million Offering of Convertible Senior Notes Due 2023
-
Westwater Resources Reports Third Quarter 2018 Operating Results
-
Form 13F-HR CANTOR FITZGERALD INVEST For: Sep 30
-
LTC Properties (LTC) PT Raised to $49 at Cantor Fitzgerald
-
CareTrust REIT (CTRE) PT Raised to $21 at Cantor Fitzgerald
-
Tahoe Resources (TAHO) PT Lowered to $5 at Cantor Fitzgerald
-
Momenta Pharmaceuticals (MNTA) PT Lowered to $16 at Cantor Fitzgerald
-
Pre-Open Movers 11/07: (TWLO) (ARRS) (GNC) Higher; (MDXG) (INFN) (INGN) Lower (more...)
-
TigerShares launches its first U.S. listed ETF, the TigerShares China-U.S. Internet Titans ETF (Ticker TTTN)
-
UPDATE: Cantor Fitzgerald Downgrades AAC Holdings (AAC) to Neutral
-
After-Hours Movers 11/06: (ARRS) (ETSY) (TWLO) Higher; (INGN) (CTSO) (ZG) Lower (more...)
-
After-Hours Movers 11/06: (ARRS) (ETSY) (TWLO) Higher; (INGN) (CTSO) (ZG) Lower (more...)
-
CytoSorbents Reports Third Quarter 2018 Financial Results
-
Cantor Fitzgerald Starts Proteostasis Therapeutics (PTI) at Overweight
-
Aptose Reports Results for the Third Quarter Ended September 30, 2018
-
Weyland Tech Provides Update Regarding Its Spin-Off of Weyland AtoZ Pay - Beneficial Owner Lists from Various Banks/Brokers Remain Outstanding
-
Weyland Tech Provides Update Regarding Its Spin-Off of Weyland AtoZ Pay - Beneficial Owner Lists from Various Banks/Brokers Remain Outstanding
-
Pre-Open Movers 11/06: (VCEL) (ELF) (MYL) Higher; (ONCS) (FTDR) (RL) Lower (more...)
-
Neos Therapeutics (NEOS) Prices 17.39M Share Common Offering at $2.30/Sh
-
SIMEC Atlantis Energy Ltd. (SAE:LN) PT Raised to GBp81 at Cantor Fitzgerald
-
After-Hours Movers 11/05: (ELF) (FN) (BKNG) Higher; (NEOS) (IIN) (MAR) Lower (more...)
-
Neos Therapeutics (NEOS) Plans Offering of Common Stock
-
Neos Therapeutics Announces Proposed Offering of Common Stock
-
Gunderson Dettmer Advises Aldeyra Therapeutics on Follow-On Public Offering
-
AcelRx Pharmaceuticals (ACRX) PT Raised to $9 at Cantor Fitzgerald
-
HMS Holdings (HMSY) PT Raised to $31 at Cantor Fitzgerald
-
Energy Fuels Renews Its ATM Program
-
Cantor Fitzgerald Starts Adverum Biotechnologies (ADVM) at Neutral
-
Cantor Fitzgerald Upgrades bluebird bio (BLUE) to Neutral
-
Emergent BioSolutions (EBS) PT Raised to $75 at Cantor Fitzgerald


